0       0


Evolving Paradigms for Lipid Emulsion Use in Clinical Practice



Credits: None available.

Description

custom image


FORMAT: Complimentary CE/CME Webcast

MAXIMUM CREDITS: Earn Up to 1.5 CPEUs, 1.5 Contact Hours, or 1.5 AMA PRA Category 1 Credits

RELEASE DATE: July 22, 2019
EXPIRATION DATE: July 31, 2020

COURSE DESCRIPTION
Research shows that intravenous lipid emulsions (ILEs) that incorporate lipid sources other than soybean oil can improve the risk/benefit ratio and outcomes of patients who require parenteral nutrition, including those who are critically ill. Alternative options have been used in Europe and around the world, and have recently expanded into the United States. On a physiologic level, the ratio of soybean, fish, and olive oils contained in various ILEs affects the omega-6 fatty acid content, which is associated with liver injury and inflammation. In contrast, recent meta-analyses have compared clinical outcomes of patients receiving fish, mixed, and soybean oil ILEs and concluded that hospital length of stay, liver function, and mortality are improved when sources of omega-3 fatty acid are used in place of or in addition to soybean oil. Initiating a switch between ILEs requires an individualized approach that takes patient-specific factors into consideration. In addition, overcoming formulary restrictions requires thoughtful analysis and demonstration of institution-specific need. The desired result of this activity is to prepare clinicians to incorporate new evidence-based parenteral nutrition strategies into practice while maximizing safety and optimizing clinical outcomes.

Jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC.

custom image


This activity is supported by an independent educational grant from Fresenius Kabi USA.

FACULTY
Beth Taylor, DCN, RDN-AP, LD, CNSC, FCCM (Chair)
Research Scientist
Department of Research for Patient Care Services
Barnes-Jewish Hospital
St Louis, Missouri

Mara Lee Beebe, MS, RD, LD, CNSC*
Nutrition Support Dietitian
The Ohio State University Wexner Medical Center
Columbus, Ohio

Todd W. Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP
Clinical Pharmacy Services Manager & Nutrition Support Team Coordinator
University of Texas MD Anderson Cancer Center
Houston, Texas

Carol S. Ireton-Jones, PhD, RD, CNSC, FASPEN
Online Instructor
Department of Nutritional Sciences
College of Human Sciences
Texas Tech University
Nutrition Therapy Specialist
Nutrishare, Inc
Good Nutrition for Good Living
Dallas, Texas

* Presenter. Presentation co-author:
Lisa Glance Mostafavifar, PharmD, BCPS, BCNSP

Specialty Practice Pharmacist
Acute Care Surgery and Trauma/Nutrition Support
PGY1 Residency Program Director
The Ohio State University Wexner Medical Center
Columbus, Ohio

CE/CME INFORMATION

Target Audience

This activity is intended for dietitians, pharmacists, nurses, and physicians engaged in the care of patients requiring parenteral nutrition.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Compare compositional differences of various lipid injectable emulsion (ILE) formulations
  • Describe the physiologic effects, efficacy, and safety of ILEs used in parenteral nutrition
  • Use effective communication strategies with health care team members for evaluating ILEs for formulary consideration
  • Demonstrate use of appropriate ILEs for hospitalized and home-based patients requiring parenteral nutrition

Joint Accreditation Statement

custom image

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedEdicus LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Dietitian Continuing Education
Postgraduate Institute for Medicine (CDR Provider #3631) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education units (CPEUs) for completion of this activity. This is a Level II activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – JA4008162-9999-19-871-H01-P)

Type of Activity: Knowledge

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.8 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Mara Lee Beebe, MS, RD, LD, CNSC
Ms Beebe has nothing to disclose.

Todd W. Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP
Consulting fees from Baxter
Fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speakers’ bureaus) from Fresenius Kabi USA

Carol S. Ireton-Jones, PhD, RD, CNSC, FASPEN
Salary from Nutrishare, Inc
Fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speakers’ bureaus) from Fresenius Kabi USA

Lisa Glance Mostafavifar, PharmD, BCPS, BCNSP
Dr Mostafavifar has nothing to disclose.

Beth Taylor, DCN, RDN-AP, LD, CNSC, FCCM
Consulting fees from Baxter; Cardinal Health; and Nestlé

Planners, Managers, and Reviewers
The PIM planners, managers, and reviewers have nothing to disclose. The MedEdicus planners and managers have nothing to disclose.

Method of Participation and Instructions for Credit
During the period July 22, 2019, through July 31, 2020, participants must 1) read the learning objectives and disclosures; 2) study the educational activity; and 3) complete the post-test with a score of 75% or better and the activity evaluation. Upon successfully completing the post-test and the activity evaluation, a certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 8 weeks.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality
For information about the activity, please contact Postgraduate Institute for Medicine (www.pimed.com) 1-800-423-3576 or email to inquiries@pimed.com.

Fee Information
There is no fee for this educational activity.

PROCEED TO PROGRAM

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content